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ABSTRACT Recent studies have investigated the dendritic actin cytoskeleton of the cell 
edge’s lamellipodial (LP) region by experimentally decreasing the activity of the actin filament 
nucleator and branch former, the Arp2/3 complex. Here we extend these studies via pharma-
cological inhibition of the Arp2/3 complex in sea urchin coelomocytes, cells that possess an 
unusually broad LP region and display correspondingly exaggerated centripetal flow. Using 
light and electron microscopy, we demonstrate that Arp2/3 complex inhibition via the drug 
CK666 dramatically altered LP actin architecture, slowed centripetal flow, drove a lamellipo-
dial-to-filopodial shape change in suspended cells, and induced a novel actin structural orga-
nization during cell spreading. A general feature of the CK666 phenotype in coelomocytes 
was transverse actin arcs, and arc generation was arrested by a formin inhibitor. We also 
demonstrate that CK666 treatment produces actin arcs in other cells with broad LP regions, 
namely fish keratocytes and Drosophila S2 cells. We hypothesize that the actin arcs made 
visible by Arp2/3 complex inhibition in coelomocytes may represent an exaggerated manifes-
tation of the elongate mother filaments that could possibly serve as the scaffold for the 
production of the dendritic actin network.
INTRODUCTION
A significant amount of research over the past decade has under-
girded the development of the dendritic nucleation model of how 
actin filaments polymerize and are structured at the leading edge of 
cells (Pollard and Borisy, 2003; Chhabra and Higgs, 2007; Le Clainche 
and Carlier, 2008; Ridley, 2011; Svitkina, 2013). At the core of this 
model is the actin filament-nucleating Arp2/3 complex, a series of 
seven proteins that orchestrates the generation of the dendritic ar-
rays of branched actin filaments characteristic of the lamellipodium 
(LP)—the outermost portion of the cell cortex, which undergoes 
rapid protrusion, retraction, and retrograde/centripetal flow 
(Goley and Welch, 2006; Pollard, 2007). A number of studies have 
focused on inhibition of the Arp2/3 complex as a means of deter-
mining the exact role that it plays and how other actin polymeriza-
tion nucleators/facilitators might contribute to the LP. Approaches 
have included using small interfering RNA (Rogers et al., 2003; 
Steffan et al., 2006; Korobova and Svitkina, 2008; Nicholson-Dystra 
and Higgs, 2008) and genetic methods (Steffan et al., 2006; Suraneni 
et al., 2012; Wu et al., 2012) to knock down or delete an Arp2/3 
complex component. Alternatively, the function of the Arp2/3 com-
plex has been interfered with via sequestration due to the presence 
of an Arp2/3 complex–binding WCA domain from one of the WASP 
family proteins (Machesky and Insall, 1998; Strasser et al., 2004; 
Koestler et al., 2013)—the nucleation-promoting factor proteins 
that serve as a bridge between signal transduction pathways and 
activation of the Arp2/3 complex. In addition, there have been phar-
macological approaches ranging from the relatively nonspecific, 
employing the drug 2,3-butanedione monoxime (BDM; Yarrow 
et al., 2003; Henson et al., 2009), to the highly specific CK drugs 
expressly designed for Arp2/3 complex inhibition (Nolen et al., 
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verse actin arcs represent an integral component of LP structure that 
may be nucleated through the action of formin-like proteins and act 
as mother filaments during the dendritic nucleation process..
RESULTS
Arp2/3 inhibition dramatically alters LP actin organization
Live-cell imaging of the actin cytoskeleton with digitally enhanced 
phase contrast microscopy (Figure 1) and fluorescence labeling of 
actin filaments via phalloidin (Figure 2, A and E–G, and Supplemen-
tal Figure S1) or anti-actin antibodies (Figure 2, B–D) in fixed cells 
revealed that treatment with the Arp2/3 inhibitor CK666 led to two 
overlapping phenotypes, both involving the replacement of the 
dendritic array of actin with assemblages of elongate filaments. 
These phenotypes represented the two most typical morphologies 
of a spectrum of responses in the cells. The most frequent was the 
transverse actin arc form, in which the LP actin network was replaced 
with a series of actin arcs oriented parallel to the cell membrane that 
were generated by a process resembling delamination from the 
membrane’s cytoplasmic face and subsequently underwent centrip-
etal flow (Figures 1, A and B, 2, B, C, and E; Supplemental Figures S1, 
C and D, S2C, and S4, A–E; and Supplemental Movies S1 and S3). 
A particularly detailed view of the stark differences between the ac-
tin dendritic array in control cells and the actin arcs in Arp2/3- inhib-
ited cells is afforded by superresolution three-dimensional (3D) 
structured illumination microscopy (SIM) of phalloidin-labeled cells 
(Supplemental Figure S1). The SIM images highlight the changes 
that CK666 treatment generated in actin structural organization not 
just within the LP, but also in the lamellar (LM) and perinuclear re-
gions of the cells (Supplemental Figure S1). Note that LP-region ac-
tin arc-like bundles were also induced in cells treated with the Arp2/3 
complex inhibitor CK869, which works via a different molecular 
mechanism than CK666 (Nolen et al., 2009), and that actin structure 
in coelomocytes treated with dimethyl sulfoxide (DMSO; drug sol-
vent) or the inactive control molecule CK689 were indistinguishable 
from untreated cells (Supplemental Figure S3).
CK666 treatment also produced another, less common pheno-
type, one dominated by filopodia in the altered LP region (Figures 
1C and 2, D and F, and Supplemental Movie S2). The elongate bun-
dles of actin in the filopodia were oriented perpendicular to the 
plasma membrane and imbedded in an array of orthogonally ori-
ented filaments similar to those seen in the actin arcs (Figures 1C 
and 2, D and F). In some instances, the filopodial extension stimu-
lated by drug treatment resulted in a slight expansion of the cell 
area, suggesting an increase in protrusive activity (Figures 1C and 
2F). Axis-independent polarization microscopy of live cells indicated 
that both the filopodia and actin arcs exhibited birefringence consis-
tent with arrays of aligned filaments (Supplemental Figure S2, A–C). 
The CK666 effect on coelomocytes was readily and rapidly revers-
ible using washes with control buffer, which resulted in the initiation 
of a new dendritic network of actin at the periphery that progressed 
inward, pushing the CK666-generated actin array ahead of it (Figures 
1B and 2G and Supplemental Movies S1 and S3). Once in the cell 
center, the drug-influenced actin cytoskeleton was dismantled, and 
eventually cells washed out of CK666 returned to completely nor-
mal morphology (Figure 1B and Supplemental Movie S1).
TEM imaging of coelomocyte cytoskeletal replicas allowed for 
fine temporal resolution analysis of the effects of both CK666 
treatment and washout on the ultrastructure of the coelomocyte 
actin cytoskeleton (Figure 3). Within 30 s of CK666 addition, the 
very dense dendritic array of branched filaments characteristic of 
the LP region of control cells (Figure 3, A and C) was replaced by a 
less dense assemblage of longer filaments, with many oriented 
Leiber et al., 2013). All of these studies have supported the general 
conclusion that the Arp2/3 complex is critical for the generation and 
maintenance of the overall structure and dynamics of the LP. Spe-
cific studies have highlighted the complex’s importance for activities 
such as cell spreading (Nicholson-Dystra and Higgs, 2008; Suraneni 
et al., 2012; Wu et al., 2012), response to the extracellular matrix 
(Wu et al., 2012), chemotaxis (Suraneni et al., 2012; Wu et al., 2012), 
retrograde flow (Henson et al., 2009; Yang et al., 2012; Koestler 
et al., 2013), and the modulation of other important LP actin cy-
toskeletal regulatory proteins, namely capping protein and cofilin 
(Koestler et al., 2013). Despite these efforts, a number of fundamen-
tal questions remain about the precise nature of the structural orga-
nization and mechanism of polymerization of the actin cytoskeleton 
in Arp2/3 complex–inhibited cells (Koestler et al., 2013).
In the present study, we use live-cell and fluorescence-based lo-
calization light microscopy and transmission electron microscopy 
(TEM) of cytoskeletal replicas to examine the effects of Arp2/3 com-
plex inhibition on the LP actin cytoskeleton in sea urchin coelomo-
cytes. These cells represent an exceptional experimental model, 
given their extraordinarily broad and Arp2/3 complex–rich LP re-
gion, exaggerated actin-based centripetal flow across the entire di-
ameter of the cell, and extreme flatness and optical clarity, allowing 
for direct observation of the actin cytoskeleton in unmanipulated 
cells. Our studies on coelomocytes suggested that Arp2/3 complex 
activity is crucial for structuring the LP actin network (Henson et al., 
1999; 2009), for the generation of the pushing-force component of 
retrograde flow (Henson et al., 1999, 2003), and for the closure of 
cytoplasmic wounds (Henson et al., 2002). The present study builds 
on our previous work with the drug BDM, which induced delocaliza-
tion of the Arp2/3 complex from the LP in coelomocytes (Henson 
et al., 2009), a result reported initially in mammalian cells (Yarrow 
et al., 2003). In addition, we extend the current literature through an 
examination of the short-time-scale transformation of the ultrastruc-
tural organization of actin in coelomocytes being both treated and 
washed out from the specific Arp2/3 complex inhibitor CK666, as 
well as the characterization of actin structure during the spreading of 
Arp2/3-inhibited cells. Furthermore, we examine specific features of 
previous studies in order to determine their relevance with regard to 
the coelomocyte system. These include the effect of CK666 on LP 
actin structure, retrograde flow rates (Yang et al., 2012; Koestler 
et al., 2013), and myosin II distribution (Koestler et al., 2013). Fur-
thermore, we initiate the process of defining the LP-specific roles of 
nucleators other than the Arp2/3 complex through the use of the 
small-molecule inhibitor of formin homology domain 2 (SMIFH2; 
Rizvi et al., 2009) in CK666-treated cells. Finally, we compare the 
results in coelomocytes with those in other cells with broad LP re-
gions, namely fish keratocytes and Drosophila S2 cells.
Our results illuminate the ultrastructural details of the significant 
transformation in the LP actin cytoskeleton that accompany Arp2/3 
complex inhibition and recovery. They suggest that transverse arcs 
of elongate actin filaments are a universal feature of cells in which 
the Arp2/3 complex is inhibited and that these arcs may represent a 
class of filaments that are nucleated by formins. In addition, Arp2/3 
inhibition significantly slows centripetal flow and the cell spreading 
process and induces a novel actin structure in spreading cells. Fur-
thermore, although we observed the limited extension of myosin II 
distribution from the cell center in coelomocytes, we did not see 
clear evidence of myosin II transport into the former LP region. Fi-
nally, we document that CK666 treatment of coelomocytes in sus-
pension induces a radical lamellipodial-to-filopodial shape change. 
Our results emphasize the major role that the Arp2/3 complex plays 
in helping organize actin architecture in cells and suggest that trans-
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arc structural organization centripetally and that the dendritic array 
grew wider over time (Figure 3, G and H). It is important to note 
that close examination of the newly forming dendritic network in 
the washed-out cell replicas revealed the existence of tangentially 
oriented elongate actin filaments (particularly noticeable in Figure 
3H) that were also present, although less obvious, in the dense LP 
network of control cells (Figure 3C). Given that the washout of the 
CK666 effect was so rapid, we were careful to include appropriate 
drug concentrations in all initial fixative and extraction buffers to 
prevent unwanted recovery of the control condition.
Arp2/3 inhibition significantly slows actin-based centripetal 
flow
Sea urchin coelomocytes in culture are characterized by persistent 
and robust centripetal flow (Henson et al., 1999, 2002, 2009), and 
analysis of centripetal flow was performed to determine whether 
diagonally or parallel to the membrane (Figure 3D). In addition, 
the tips of bundles of actin filaments are seen to be associated 
with small, pyramid-shaped protrusions on the membrane (Figure 
3D), which were also seen in live-cell (Figure 1, A, boxed region of 
the 30-s image, and C) and fluorescence microscopy (Figure 2D). 
Consistent with light microscopic imaging (Figures 1, A and B, and 
2E, and Supplemental Figure S1), TEM also revealed that with in-
creasing time of CK666 treatment, the peripheral actin arcs be-
came more and more dominant and less dense (Figure 3, E and F) 
and tended to occupy an increasing percentage of the diameter of 
the cell (Figure 3B). The arcs consisted of lose bundles of elongate 
and typically unbranched actin filaments (Figure 3F) and were ul-
trastructurally similar to the actin arcs produced by treating coelo-
mocytes with BDM (Henson et al., 2009). TEM imaging of CK666 
washout showed that within seconds, the cell edge produced a 
control-like assemblage of dendritic actin that displaced the actin 
FIGURE 1: Arp2/3 complex inhibition radically transforms the coelomocyte LP actin cytoskeleton. Live-cell phase 
contrast images from two digital movies shows that 100 μM CK666 treatment results in two basic phenotypes—a more 
common, transverse arc form (A, B) and a less common, filopodial form (C). In each case, the dense dendritic array of the 
control cells is replaced with less dense assemblages of elongate filaments. The effects of CK666 are readily reversible, 
as illustrated in the sequential wash out (+WO) images in B, in which the actin arcs are completely replaced by the control 
actin organization. The box in the 30-s post-CK666 treatment image in A denotes a region of the cell that generates a 
response analogous to that seen in the TEM image in Figure 3D. Bar, 10 μm; magnifications of A–C are equivalent.
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cell in Figure 5, D–F), whereas strong actin arcs and weak Arp3 stain-
ing are seen in the other (right-hand cell in Figure 5, D–F). In addi-
tion, pixel intensity measurements of control (+CK689) and Arp2/3 
complex–inhibited cells (+CK666 or +CK869) demonstrate a greatly 
diminished Arp3 localization signal in the latter cells (Supplemental 
Figure S4). In previous work, we demonstrated that Arp3 staining 
is delocalized from the edge of coelomocytes treated with BDM 
(Henson et al., 2009). However, unlike the overall diminishment of 
the Arp3 label in cells treated with CK666, Arp3 staining is retained 
in the central cytoskeleton of the BDM-treated cells (see Figure 1 in 
Henson et al., 2009). This suggests that CK666 eliminates the incor-
poration of the Arp2/3 complex from assembling actin filaments 
and also induces dissociation of the Arp2/3 complex from the previ-
ously formed dendritic actin cytoskeleton (also suggested by Yang 
et al., 2012), whereas BDM selectively interferes with only the pe-
ripheral localization of Arp2/3 complex (a hypothesis that is also 
supported by some of our recent unpublished results comparing the 
effects of BDM and CK666).
In earlier work, we demonstrated that a centrally located array of 
actin and myosin II provides the contractile pulling force component 
of coelomocyte centripetal flow (Henson et al., 1999, 2003, 2009). 
Therefore, as expected, control cells contained a tightly focused ar-
ray of perinuclear myosin labeling (Figure 5, G–I). Treatment with 
CK666 resulted in a spreading of the myosin staining pattern (Figure 
5, J–L) in concert with an overall relaxation of the actomyosin ring 
present in the cell center (as seen in the SIM-imaged, phalloidin-
stained cells in Supplemental Figure S1, C and D), a response also 
seen in cells treated with BDM (Henson et al., 2009). Note that in 
CK666-treated cells, the myosin II tended to localize in radially ar-
ranged ribs that serve as collection sites for the centripetal migration 
of actin arcs (Figure 5, J–L, and Supplemental Movies S1 and S3). 
Arp2/3 inhibition altered the speed of the movement (Figure 4, A–E 
and K). Measurements of 20 different cells before and after drug 
treatment indicated that coelomocyte centripetal flow slowed sig-
nificantly (p < 0.001) when treated with CK666 and increased signifi-
cantly (p < 0.001) when washed out of the drug (Figure 4, K and L). 
The significant effect of Arp2/3 complex inhibition underscores the 
importance of its function in the maintenance of the rapid centripe-
tal flow rates characteristic of the LP region. To verify that actin po-
lymerization was indeed responsible for the production and flow of 
the CK666-induced arcs, we treated cells initially with CK666, fol-
lowed by a combined treatment of CK666 plus the actin polymeriza-
tion–disrupting drug cytochalasin D (CytoD). Treatment with CytoD 
resulted in the gradual arrest of arc formation and a clearing of the 
cortical region due to the retraction of the central cytoskeleton as a 
consequence of continued actomyosin contraction (Figure 4, F–J). 
During this retraction, a minority of arcs maintained a single point of 
contact with the membrane at the cell edge (Figure 4J). We previ-
ously reported on CytoD’s ability to produce cleared fringes and 
central cytoskeletal contraction in coelomocytes (Henson et al., 
2002, 2009), a response that is reminiscent of the cytochalasin phe-
notype originally demonstrated in Aplysia growth cones (Forscher 
and Smith, 1988).
Arp2/3 complex inhibition alters the distribution of the 
complex and myosin II
Immunolocalization of actin and Arp3 indicated that CK666 treat-
ment resulted in an overall decrease in Arp3 labeling, as well as loss 
of Arp3 signal from the LP region of cells displaying the actin arc 
phenotype (Figure 5, A–F). The validity of this change in localization 
is supported by images showing two adjacent cells in which strong 
dendritic actin and Arp3 labeling overlap is seen in one (left-hand 
FIGURE 2: Fluorescence staining of actin in Arp2/3 complex–inhibited coelomocytes. Fluorescent phalloidin (A, E–G) 
and actin antibody staining (B–D) of cells treated with 100 μM CK666 corroborates the live-cell imaging in depicting the 
transition of the control dendritic network (A) into the actin arcs (B, C, E) and actin filopodia (D, F) present in CK666-
affected cells. Washing the cells out of CK666 with control buffer (+WO; G) rapidly reestablishes the control dendritic 
array at the cell edge, which then moves centripetally. Bar, 10 μm; magnifications of A, B, and E–G are equivalent.
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lamellipodia to one containing numerous elongate filopodia (Figure 
6, D and I–K, and Supplemental Figure S2, D and E), and, as part of 
these experiments, we investigated the ability of the CK666-treated 
cells to spread on a substrate. Consistent with a previous study us-
ing a short hairpin RNA (shRNA) depletion approach in mammalian 
fibroblasts and lymphocytes (Nicholson-Dystra and Higgs, 2008), 
we found that CK666-based Arp2/3 inhibition slowed the progress 
of cell spreading relative to control cells (Figure 6, A–J and L). In ad-
dition, Arp2/3 complex inhibition greatly altered the structural orga-
nization of actin in the spreading cells (Figure 6, A–J). Filopodia from 
control coelomocytes typically return to their lamellipodial form dur-
ing the spreading process, as was seen when cells transformed to 
the filopodial form by CK666 treatment in suspension were allowed 
to attach briefly to a coverslip and then washed out of the drug us-
ing control buffer (Figure 6, A–C, G, and H). In these control cells, 
the filopodia were consumed by the rapid spreading out of numer-
ous LPs containing the expected dendritic array of actin filaments, 
as demonstrated by phalloidin staining (Figure 6, A and C) and TEM 
Although the myosin distribution did spread out as a result of CK666 
treatment, there was little evidence of the transport of myosin to the 
cell edge as reported by Koestler et al. (2013).
Arp2/3 inhibition in suspended coelomocytes drives a 
lamellipodial-to-filopodial shape change and alters the 
dynamics and structure of actin during spreading
Early studies on coelomocytes demonstrated that these cells un-
dergo a dramatic lamellipodial-to-filopodial shape change when 
challenged in suspension with hypotonic shock (Edds, 1979; Otto 
et al., 1979) or treatment with calcium ionophore (Henson and Shat-
ten, 1983; Hyatt et al., 1984). Arp2/3 complex inhibition in other cell 
types has been shown to be associated with an increase in filopodia 
(Nicholson-Dystra and Higgs, 2008; Suraneni et al., 2012; Wu et al., 
2012; Koestler et al., 2013), and we saw this to a limited degree in 
attached cells treated with CK666 (Figures 1C and 2, D and F). In 
contrast, treatment of coelomocytes in suspension resulted in the 
transformation of the cells from a form possessing a number of 
FIGURE 3: Ultrastructure of the alteration of actin organization during Arp2/3 complex inhibition. Control cells 
(A, C) contain a dense dendritic network of actin filaments in their LP region, which, upon treatment with 100 μM 
CK666, rapidly transitions to an array of less dense elongate filaments oriented diagonally and parallel to the membrane 
(D, E). The pyramidal projections seen in D are analogous to the similar structures apparent in the live-cell imaging in the 
boxed region of the 30-s image in Figure 1A. Over time, the transverse actin arcs become apparent, decrease in density, 
and tend to occupy more of the cell diameter (B, F) and consist of loosely affiliated and highly elongate actin filaments. 
Washout of CK666 (G, H) results in the immediate restart of the dense dendritic actin network at the cell edge, and this 
pushes centripetally, and elongate actin filaments oriented at low angles to the membrane are apparent within this 
network. Bar, 5 μm (A), 1 μm (C); magnifications of A, B, and C–H are equivalent.
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treatment resulted in the initial slowing of arc centripetal flow and 
the eventual arrest of their generation from the cell edge (Supple-
mental Movie S5 and Figure 8A). Live-cell (Figure 8B), phalloidin 
staining (Figure 8C), and TEM (Figure 8, D and E) images of the ef-
fect of formin inhibition alone on control cells showed that this drug 
leads to a cell-wide disruption in actin architecture in which the 
effected cells displayed patches of dense and less dense actin net-
works. This patchy distribution of actin networks was similar to that 
reported by Yang et al. (2007) in TEM images of mammalian cells in 
which formin/mDia was depleted by shRNA treatment. Note that 
normal actin organization could be restored in coelomocytes washed 
out of the SMIFH2 drug (Supplemental Movie S6 and Figure 8, F–I).
Other cell types with broad LP regions—fish keratocytes 
and Drosophila S2 cells— generate actin arcs on Arp2/3 
complex inhibition
The central nature of actin arcs in the coelomocyte response to 
Arp2/3 complex inhibition led us to postulate that other cell types 
containing broad LP regions would respond in a similar manner. We 
initially focused on fish keratocytes and found that CK666 treatment 
slowed or halted keratocyte migration (unpublished data) and pro-
duced actin arcs in the LP region that were visible with phalloidin 
staining (Figure 9, A–H) and were reminiscent of the arcs present in 
coelomocytes. During the course of these experiments, we learned 
of recent work that also reported the presence of actin filaments 
parallel to the membrane in fish keratocytes in which the Arp2/3 
(Figure 7, A–C). In contrast, cells spreading in the presence of CK666 
showed that their LP regions contained actin arcs (Figures 6, D–F 
and J, and 7, D–F) similar to that seen in drug-treated attached cells 
(Figures 1–4). Moreover, these structures were birefringent, as de-
tected by polarizing microscopy (Supplemental Figure S2F), arose 
from the cell edge, and underwent centripetal flow (Supplemental 
Movie S4). In addition, unlike the smooth process of spreading ex-
hibited by the LPs in the control cells, the edges of CK666-treated 
cells tended to undergo intermittent/jerky protrusive activity (Sup-
plemental Movie S4). In instances of the spreading around points at 
which filopodia touched the substrate, the actin arcs formed an un-
usual concentric circle pattern as seen in phalloidin labeling (arrow 
in Figure 6F) and TEM (Figure 7, F and H). These images suggested 
that the actin reorganization accompanying the spreading of CK666-
treated cells was fundamentally different from controls and did not 
involve the formation of LP-like regions with dendritic networks of 
filaments. They also indicate that coelomocytes retain the ability to 
spread even in the absence of the ability to form a conventional LP 
architecture.
Formin inhibition arrests the CK666-induced production 
of actin arcs
To test our working hypothesis that the CK666-induced actin arcs 
are the result of formin-facilitated actin polymerization, we treated 
coelomocytes initially with CK666, followed by a mixture of CK666 
plus SMIFH2, which is described in Risvi et al. (2009). SMIFH2 
FIGURE 4: CK666-induced actin arcs delaminate from the cell edge, undergo decreased centripetal flow, and are 
arrested by CytoD treatment. Phase contrast digital movies reveal the delamination-like generation of actin arcs in a cell 
treated with 100 μM CK666 (A–E; 50 s between images; 1–3 mark three consecutive arcs) and that arc production can 
be arrested by treatment with 500 nM CytoD (F–J; time between images is 60 s for F–I and 180 s for I to J). 
Quantification of average (K) and percentage previous (L) centripetal flow rates shows that CK666 treatment 
significantly slows centripetal flow. ***Statistically significant differences at the p < 0.001 level. Bar, 10 μm; 
magnifications of A–J are equivalent.
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decrease in centripetal flow, 3) a limited redistribution of the peri-
nuclear myosin II distribution, 4) a transformation of suspended cells 
from a lamellipodial to a filopodial form, and 5) a slowing of the cell 
spreading process and a novel alteration in the actin structure of 
spreading cells. We also show that a formin inhibitor arrests the pro-
duction of the actin arcs induced by Arp2/3 complex inhibition. 
Each of these main results will be discussed in the context of the 
literature.
A number of previous studies on several different cell types 
demonstrated the presence of elongate actin filaments oriented 
parallel to the plasma membrane, using TEM imaging of cells in 
which Arp2/3 complex activity had been reduced using a variety 
of approaches (Steffan et al., 2006; Korobova and Svitkina, 2008; 
Wu et al., 2012; Yang et al., 2012; Koestler et al., 2013; Lieber 
et al., 2013). The presence of the elongate filaments in these 
complex was inhibited by either treatment with CK666 (Koestler 
et al., 2013; Lieber et al., 2013) or WCA-based sequestration 
(Koestler et al., 2013). In other experiments, we tested the effect of 
CK666 treatment on Drosophila S2 cells and discovered that they 
also respond to Arp2/3 complex inhibition by the generation of LP 
actin arcs (Figure 9, I–P). These results with two cell types widely 
separated phylogenetically underscore the universality and signifi-
cance of the actin arc response to Arp2/3 inhibition in cells contain-
ing wide LP regions.
DISCUSSION
In the present study, we demonstrate that pharmacological inhibi-
tion of the Arp2/3 complex in sea urchin coelomocytes leads to 
1) a radical restructuring of the LP actin cytoskeleton, with the as-
sociated generation of actin arcs from the cell edge, 2) a significant 
FIGURE 5: The distributions of Arp2/3 complex and myosin II are altered by CK666 treatment. Immunofluorescence 
labeling of actin (A, D, green in C and F) and Arp3 (B, E, magenta in C and F) in control (A–C) and 100 μM CK666–
treated (D–F) cells shows that the dense Arp3 labeling apparent in control cells is substantially decreased in cells 
containing the CK666-induced actin arc phenotype (right-hand cell in D–F). Staining for actin (G, J, green in I and J) and 
myosin II (H, K, magenta in I and L) in control (G–I) and 100 μM CK666–treated (J–L) cells demonstrates that the tightly 
compacted perinuclear myosin II ring apparent in control cells becomes more spread in cells exhibiting a CK666-induced 
actin arc phenotype. Nuclei in C, F, I, and L are labeled blue. Bar, 10 μm; magnifications of A–F and G–L are equivalent.
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FIGURE 6: Arp2/3 complex inhibition retards the process of coelomocyte spreading and induces a novel actin 
organization. Cells treated in suspension with 100 μM CK666 undergo a lamellipodial-to-filopodial shape change, 
as seen when allowed to settle for 5 min and stained with phalloidin (D). In contrast, cells washed out of the drug 
just after substrate attachment and imaged 5 min later (A) show numerous LP-like spreading regions. With 
increasing time post settling (B and E, 15 min; C and F, 20 min; G–J, 45 min), control cells (B, C, G, H) spread into 
the typical discoidal morphology, with prominent LP dendritic arrays, whereas the spreading CK666-treated cells 
(E, F, I, J) have processes containing noticeable actin arcs and numerous filopodia. In these cells, the processes 
produced in regions of spreading from filopodia making focal substrate contacts can contain novel concentric circle 
patterns of actin arcs (arrow in F). Quantification shows that CK666 treatment of coelomocytes in suspension 
induces a significantly larger number of filopodial cells than control treatment with CK689 (K; p < 0.001) and that 
control/washout cells spread faster than cells kept in the presence of the drug (L). Bars, 10 μm; magnifications of 
A–F and G–J are equivalent.
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An important question about the CK666-induced actin arcs in 
coelomocytes is whether they are similar to the transverse actin arcs 
long known to be present in the LM region of many other cell types 
(Heath, 1983; Small and Resch, 2005; Hotulainen and Lappalainen, 
2006; Burnette et al., 2011). These structures tend to arise proximal 
to the LP/LM interface and are characterized by tightly bundled ac-
tin filaments with associated α-actinin and myosin II, features that 
are not shared by the CK666-induced coelomocyte arcs. The CK666-
associated arcs may represent an immature form of organization, 
given that arcs have been shown to evolve over the time between 
their initial polymerization and maturation into a contractile bundle 
(Hotulainen and Lappalainen, 2006). However, control coelomo-
cytes lack obvious transversely oriented actin arcs, and instead their 
interior LM region is dominated by the presence of large, radially 
oriented bundles of elongate actin filaments (Figures 1A and 2A 
and Supplemental Figure S1, A and B) that are not associated with 
various cell types was often relatively subtle and difficult to visual-
ize using light microscopy, whereas in the coelomocyte, the edge-
associated elongate actin filaments form well-defined arc-like 
structures that can be clearly visualized in live, unlabeled cells 
(Figures 1 and 4, Supplemental Figure S2, and Supplemental 
Movies S1–S3). Our speculation is that the uniquely broad nature 
of the LP region of coelomocytes allows for this exaggerated re-
sponse to CK666 treatment, and we show that actin arcs are in-
duced in other cell types that also contain broad LP regions, 
namely fish keratocytes and Drosophila S2 cells (Figure 9). We 
previously reported that actin arcs were induced in coelomocytes 
by treatment with the drug BDM (Henson et al., 2009), and the 
replication of this BDM phenotype with the specific inhibitor 
CK666 supports our hypothesis that at least one of the indirect 
effects of the drug BDM is to interfere with Arp2/3 complex activ-
ity/localization.
FIGURE 7: Ultrastructural organization of actin in control and Arp2/3 complex–inhibited spreading cells. TEM imaging 
of control/washout cells settled for 15 min (A–C, G) shows that the spreading peripheral regions contain the expected 
LP-like dendritic actin network (A, B). In contrast, cells spreading in the presence of 100 μM CK666 for 15 min (D–F, H) 
possess more- limited spread regions containing actin arcs of elongated filaments (D, E). In spreading filopodial regions, 
control cells show evidence of small regions of dendritic actin arrays (C, G), whereas CK666-affected cells display actin 
arcs arrayed in unusual concentric circle patterns (F, H). Bars, 2 μm (A, D), 0.5 μm (B, C, E–H).
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In terms of the actin polymerization mechanism responsible for 
generating arcs, we demonstrate that a formin inhibitor (SMIFH2) 
arrests the production of the CK666-induced arcs in coelomocytes 
(Figure 8) and that the actin structural changes elicited by this inhib-
itor in coelomocytes resemble those seen in another study using 
shRNA against formin/mDia in mammalian cells (Yang et al., 2007). 
In addition, Suraneni et al. (2012) demonstrated that formin/mDia 
proteins localized to the tips of filopodium-like structures in cells 
devoid of the Arp2/3 complex. Therefore it is possible that formin/
mDia proteins are mediating the polymerization of the actin arcs, 
although Ena/VASP-like proteins (Bear and Gertler, 2009) could also 
be involved. With regard to arc motility, our previous work with 
BDM-induced arcs (Henson et al., 2009) and present experiments 
with the CK666-treated cells suggest that myosin II contraction 
plays a role in their centripetal motility, consistent with other studies 
involving Arp2/3 inhibition (Yang et al., 2012; Koestler et al., 2013).
The significant decrease in centripetal/retrograde flow that we 
report for Arp2/3 complex–inhibited coelomocytes (Figure 4) is 
myosin II in control cells (Figure 5; Henson et al., 1999, 2003). We 
speculate that coelomocyte LP arcs are not equivalent to the arcs 
present in the LM of other cells and instead represent elongate fila-
ments typically formed in the LP region of control cells but are hid-
den within the high-density dendritic actin network (Figure 3). Koes-
tler et al. (2008) reported that elongate actin filaments parallel to the 
cell edge and similar to coelomocyte arcs were most prominent in 
areas of cells not undergoing active protrusion.
An intriguing possibility is that the arcs of parallel actin filaments 
seen in CK666-treated coelomocytes may represent the “mother” 
filaments onto which the Apr2/3 complex must bind to generate 
side branches (Gupton et al., 2007; Yang et al., 2007). Vinzenz et al. 
(2012) used a single cell wounding approach in mammalian cultured 
cells—first developed in our lab using coelomocytes (Henson et al., 
2002)—to demonstrate that Arp2/3 complex–dependent branches 
form off of layers of elongate filaments oriented parallel to the 
wound edge membrane, and these filament layers are reminiscent 
of the CK666-induced arcs in coelomocytes.
FIGURE 8: The generation of actin arcs in Arp2/3 complex–inhibited cells is arrested by treatment with the formin 
inhibitor SMIFH2. Phase contrast digital movie of a cell treated with 100 μM CK666 followed by treatment with CK666 
plus 5 μM SMIFH2 (A; time between the first and second images is 10 s and between subsequent images is 60 s). Arc 
generation and centripetal movement continued briefly after SMIFH2 application (note movement of arcs 1 and 2 and 
production of arc 3) and then was clearly arrested. Treating control cells with 2.5–5 μM SMIFH2 (B–E) for 10 min resulted 
in the patchy, discontinuous distribution of actin networks as seen in live-cell phase contrast (B), fluorescent phalloidin 
staining of actin (C), and TEM imaging (D, E). A control cell (F) treated with 2.5 μM SMIFH2 for 10 min (G) shows 
disruption in the actin cytoskeleton. Washing out the drug for 2 (H) or 15 min (I) restores the control actin structural 
organization (I). Bars,10 μm (A, F), 5 μm (E); magnifications of A–C and F–I are equivalent.
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region (Yang et al., 2012), whereas filopodia are rare in control coelo-
mocytes (Figures 1–5). In the growth cones, CK666 treatment would 
spare the filopodia, and therefore increased flow might be expected 
as a result of a shift of actin polymerization from numerous edge-as-
sociated sites to fewer filopodial tips, and, in agreement with this 
idea, the filopodia in the CK666-treated cells do appear longer and 
more robust (Yang et al., 2012). It is interesting that an older study 
demonstrated that BDM treatment of Aplysia growth cones also 
tended to result in the growth of filopodia (Lin et al., 1996), suggest-
ing that there might be some overlap in the effects of CK666 and 
BDM in growth cones similar to what we show for coelomocytes.
consistent with previous studies using cultured mammalian fibro-
blasts (Koestler et al., 2013) and neuronal cells (Korobova and 
Svitkina, 2008) but conflicts with the results of Yang et al. (2012) using 
Aplysia growth cones. This last study indicated that treating growth 
cones with CK666 resulted in the significant acceleration of retro-
grade flow and that the slowing of flow with CK666 treatment was 
only seen in cells pretreated with the myosin II inhibitor blebbistatin. 
The differential response of Aplysia growth cones and coelomocytes 
to Arp2/3 complex inhibition is not surprising, given the substantial 
differences in their actin cytoskeletal organization. The growth cones 
contain numerous edge-associated filopodia in their LP-equivalent P 
FIGURE 9: Inhibition of the Arp2/3 complex in fish keratocytes and S2 cells induces actin arc formation. Phase contrast 
(A, C, E, G) and fluorescent phalloidin (B, D, F, H) imaging of control (A–D) and 100 μM CK666–treated (E–H) fish 
keratocytes demonstrates that the drug transforms the LP region from a dendritic network into a collection of 
transverse, elongate filaments. A similar response is seen when control S2 cells (I–L) are treated with 100 μM CK666 
(M–P), suggesting that actin arcs are a common feature of Arp2/3 complex inhibition in cells with broad LP regions. Bar, 
10 μm; magnifications of A–P are equivalent.
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the scales of goldfish (Carrasius auratus) following the methods of 
Svitkina et al. (1997) and cultured at room temperature in DMEM 
plus 20% fetal bovine serum. Drosophila S2 cells were purchased 
from the American Type Culture Collection (Manassas, VA) and cul-
tured in Schnieder’s medium plus 10% fetal bovine serum at room 
temperature using the methods of Rogers and Rogers (2008). A 
rabbit polyclonal antibody against sea urchin egg myosin II heavy 
chain was generated from protein precipitated from sea urchin egg 
extracts and electrophoretically purified (Henson et al., 1999). A 
monoclonal anti-actin antibody (clone C4) was obtained from MP 
Biomedicals (Santa Ana, CA), fluorescent phalloidin was purchased 
from Molecular Probes (Eugene, OR), TEM supplies and reagents 
were obtained from Electron Microscopy Sciences (Hatfield, PA), 
CK666, CK689, CK869, and SMIFH2 were all obtained from Calbio-
chem (San Diego, CA), and the majority of other reagents and anti-
bodies were purchased from Sigma-Aldrich (St. Louis, MO).
Pharmacological treatments
For pharmacological treatments, cells being processed for fluores-
cence staining or electron microscopy were treated in 35-mm Petri 
dishes, and cells prepared for live-cell imaging were treated in sim-
ple perfusion chambers. These chambers were created by placing 
the coverslip containing cells on top of shims made of cut cover-
slips attached to a slide via petroleum jelly. Alternatively, coverslips 
were attached to shims made of double-stick adhesive tape. Solu-
tions containing a drug were perfused through the chamber using 
the capillary action of a piece of filter paper. CK666 and CK869, the 
two active Arp2/3 complex inhibitors, and the inactive homologue, 
CK689, were made up as 50 mM stock solutions in DMSO and typi-
cally used at 100 μM (after extensive vortexing in CCM to avoid 
precipitation). Cytochalasin D was made up as 1 mM stock in DMSO 
and used at a concentration of 500 nM to 1 μM. The formin inhibi-
tor SMIFH2 was made up as 50 mM stock solutions in DMSO and 
used at a concentration of 2.5–5 μM (after extensive vortexing in 
CCM to avoid precipitation). DMSO-alone control treatments were 
performed as part of every experiment involving drug treatment.
Live-cell imaging
Coelomocytes were settled onto alcohol-washed glass coverslips 
that were mounted on perfusion chambers and were viewed on a 
Nikon (Tokyo, Japan) 80i microscope using either a 40×/0.75 nu-
merical aperture (NA) phase contrast plan objective lens or a 
60×/1.4 NA phase contrast planapochromatic objective lens. Digi-
tally enhanced phase contrast images were obtained with a Hitachi 
(Tokyo, Japan) charge-coupled device (CCD) camera coupled to a 
Hamamatsu (Hamamatsu City, Japan) Argus-10 real-time digital im-
age processor. Frame-averaged, background-subtracted, and con-
trast-enhanced images were imported into ImageJ (National Insti-
tutes of Health, Bethesda, MD), where additional digital contrast 
enhancement and frame averaging was performed.
For axis-independent polarization microscopy and differential 
interference contrast (DIC) imaging, cells in perfusion chambers 
were viewed on an LC-PolScope (Cambridge Research and In-
strumentation, Hopkinton, MA) using a strain-free 60×/1.4 NA 
DIC planapochromatic objective lens mounted on a Nikon Micro-
phot SA microscope, and images were captured using a Q-Imag-
ing (Surrey, Canada) Retiga camera and processed using Micro-
manager-based LC PolScope-specific software.
Fluorescence localization
For fluorescence localization of filamentous actin with phalloidin, 
coelomocytes were fixed with 0.25% glutaraldehyde plus 0.1% 
In terms of myosin II labeling, CK666 treatment of coelomocytes 
does induce a limited spreading of the myosin II array located in the 
center of control cells (see also Henson et al., 1999, 2003), and this 
more widely distributed myosin II tends to concentrate along radial 
ridges in the cytoskeleton that correspond to collection sites for ac-
tin arcs (Figures 1, 4, and 5), where actomyosin contraction may be 
providing a pulling force for their centripetal movement. Koestler 
et al. (2013) report that in fibroblasts, Arp2/3 complex inhibition 
leads to myosin II patch movement from the LM to nearer the cell 
edge and distal of the former LM/LP boundary. In coelomocytes, 
myosin II does not associate with the CK666-induced actin arcs and 
does not appear to spread into the LP region, a result also reported 
in CK666-treated Aplysia growth cones (Yang et al., 2012).
The LP region would be expected to be involved in the process 
of cells spreading out on a substrate, and earlier work in mammalian 
cells showed that depletion of the Arp2/3 complex does interfere 
with the spreading process (Nicholson-Dystra and Higgs, 2008; 
Suraneni et al., 2012; Wu et al., 2012). Our findings in coelomocytes 
confirm these results, given that CK666 treatment slows spreading 
of coelomocytes (Figure 6), and also extend them by our demonstra-
tion of the unusual actin structural organization present in CK666-
treated spreading cells (Figures 6 and 7). This actin organization is 
characterized by arcs similar in structure and dynamics to those pres-
ent in cells treated while attached and an overall lack of the dendritic 
networks present in the LPs of spreading control cells (Figures 6 and 
7). The CK666-treated cells do slowly spread over time, and the actin 
arcs create unusual patterns such as the concentric circle arrays pres-
ent at the tips of substrate-associated filopodia (Figures 6 and 7).
In summary, in the present study, we demonstrate that Arp2/3 
complex inhibition leads to the formation of actin arcs in coelomo-
cytes and other cell types with broad lamellipodial regions, that 
these arcs are involved in cells spreading in the absence of Arp2/3 
complex function, and that arc generation is arrested by formin inhi-
bition. Our hypothetical model explaining the generation of arcs in 
CK666 treated cells involves the following steps: 1) CK666-induced 
loss of Arp2/3 complex function leads to a rapid and significant de-
crease in the number of sites for actin filament polymerization in the 
LP, given the loss of actin branch points on preexisting mother fila-
ments; 2) actin monomers now preferentially add onto the mem-
brane-associated barbed ends of the much fewer preexisting elon-
gate filaments that are nucleated by formin, and this can take place 
in an arc and/or filopodial morphology; and 3) rapid polymerization 
of the actin arcs combined with a lower level of “pushing” force due 
to the loss of the dendritic array causes them to accumulate along 
the cytoplasmic face of the membrane, where their delamination 
and centripetal movement are driven by myosin II–based pulling 
from the interior of the cell. We are pursuing additional experiments 
to test this conceptual model.
MATERIALS AND METHODS
Animals, cell preparation, antibodies, and reagents
Sea urchins of the species Strongylocentrotus droebachiensis were 
either collected from the near-shore waters surrounding the Mount 
Desert Island Biological Laboratory (Salsbury Cove, ME) or obtained 
from the MBL Marine Resources Center (Woods Hole, MA) and kept 
in either running sea water or closed artificial sea water systems at 
4–15°C. Coelomocytes were isolated and maintained as described 
in Henson et al. (1992) with the coelomocyte culture medium (CCM) 
consisting of 0.5 M NaCl, 5 mM MgCl2, 1 mM ethylene glycol tet-
raacetic acid (EGTA), and 20 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid, pH 7.2. Typically the cells were used within 
24–36 h of isolation. Fish epidermal keratocytes were obtained from 
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